 Participants will be randomly assigned to receive either St. Johns wort or placebo daily for 10 weeks. Self-report scales will be used to assess participants GSAD symptoms at study entry and at study completion. Blood collection will occur at every weekly study visit to determine the levels of St. Johns wort in the blood. 